Arcellx (ACLX) Cash from Operations (2021 - 2025)
Arcellx's (ACLX) quarterly Cash from Operations came in at 58175000.0 in Q4 2025, down 26.38% year-on-year from 79025977.57 in Q4 2024, and down 18.23% quarter-over-quarter from 49207000.0 in Q3 2025.
Arcellx (ACLX) Cash from Operations (2021 - 2025) Analysis & Trends
Arcellx's Cash from Operations history runs 5 years deep, the most recent figure standing at 58175000.0 for Q4 2025.
- On a quarterly basis, Cash from Operations fell 26.38% year-over-year to 58175000.0 in Q4 2025; TTM through Dec 2025 was 210258000.0, a 151.91% decrease from a year earlier, with the FY2025 full-year figure at 210258000.0, down 151.91% from the prior year.
- Cash from Operations slipped to 58175000.0 in Q4 2025 per ACLX's latest filing, from 49207000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 182042000.0 in Q1 2023 and bottomed at 63145000.0 in Q1 2025.
- The 5-year median for Cash from Operations is 22581500.0 (2022), against an average of 11984650.0.
- Across the five-year window, Cash from Operations soared 658.65% in 2023 and plunged 260.18% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 21546000.0 in 2021, then declined by 27.73% to 27520000.0 in 2022, then surged by 311.66% to 58248000.0 in 2023, then slumped by 179.02% to 46030000.0 in 2024, then fell by 26.38% to 58175000.0 in 2025.
- Per Business Quant, the three latest ACLX Cash from Operations figures stand at 58175000.0 (Q4 2025), 49207000.0 (Q3 2025), and 39731000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -58.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -58.18 Mn |
| Dec 31, 2025 | -58.18 Mn |
| Sep 30, 2025 | -49.21 Mn |
| Sep 30, 2025 | -49.21 Mn |
| Jun 30, 2025 | -39.73 Mn |
| Jun 30, 2025 | -39.73 Mn |
| Mar 31, 2025 | -63.15 Mn |
| Mar 31, 2025 | -63.15 Mn |
| Dec 31, 2024 | -46.03 Mn |
| Dec 31, 2024 | -46.03 Mn |
| Sep 30, 2024 | 30.72 Mn |
| Sep 30, 2024 | 30.72 Mn |
| Jun 30, 2024 | -36.25 Mn |
| Jun 30, 2024 | -36.25 Mn |
| Mar 31, 2024 | -31.91 Mn |
| Mar 31, 2024 | -31.91 Mn |
| Dec 31, 2023 | 58.25 Mn |
| Dec 31, 2023 | 58.25 Mn |
| Sep 30, 2023 | -10.10 Mn |
| Sep 30, 2023 | -10.10 Mn |